A protective effect of sulphinpyrazone against coronary occlusion-induced shortening of myocardial refractory periods in the rat
- PMID: 3708212
- PMCID: PMC1917107
- DOI: 10.1111/j.1476-5381.1986.tb09480.x
A protective effect of sulphinpyrazone against coronary occlusion-induced shortening of myocardial refractory periods in the rat
Abstract
The hearts of anaesthetized, artificially ventilated rats were exposed, and the left coronary artery occluded. The diastolic threshold voltage for stimulation (DTV), the duration of the bipolar electrogram (DBE) and the functional refractory period (FRP) of the ischaemic area were measured at minute intervals for an hour after occlusion. Coronary occlusion caused a rise in DTV, a prolongation of the DBE and a biphasic change in the FRP, with an initial prolongation phase (1-4 min) followed by a decline to below pre-occlusion values (5-15 min). Episodes of ventricular tachyarrhythmia (VT) were most frequent during the period 5-15 min after the onset of occlusion of the coronary artery. This coincided with the period when FRP was minimal and the difference between DBE and FRP was maximal. Pretreatment of rats with sulphinpyrazone (2.5-40 mg kg-1) or indomethacin (5-20 mg kg-1) protected against the episodes of coronary occlusion-induced VT and against the associated decline in FRP of the ischaemic muscle. Sulphinpyrazone was more effective than indomethacin in this respect and a combination of the two drugs was approximately as effective as sulphinpyrazone alone. It was concluded that sulphinpyrazone protects rats against coronary occlusion-induced episodes of VT by reducing the risk of ventricular action potential re-entry. This effect is probably due to protection against the ischaemia-induced shortening of the myocardial FRP.
Similar articles
-
Electrical changes produced by injury to the rat myocardium in vitro and the protective effects of certain antiarrhythmic drugs.Br J Pharmacol. 1987 Jan;90(1):131-8. doi: 10.1111/j.1476-5381.1987.tb16832.x. Br J Pharmacol. 1987. PMID: 3814915 Free PMC article.
-
A direct protective effect of sulphinpyrazone on ischaemic and reperfused rat hearts.Br J Pharmacol. 1984 Sep;83(1):221-6. doi: 10.1111/j.1476-5381.1984.tb10138.x. Br J Pharmacol. 1984. PMID: 6487890 Free PMC article.
-
Haemodynamic effects of sulphinpyrazone in experimental myocardial ischaemia.Br J Pharmacol. 1981 Jan;72(1):5-7. doi: 10.1111/j.1476-5381.1981.tb09095.x. Br J Pharmacol. 1981. PMID: 7225713 Free PMC article.
-
Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: role of nitric oxide.J Mol Cell Cardiol. 1999 Jun;31(6):1229-41. doi: 10.1006/jmcc.1999.0955. J Mol Cell Cardiol. 1999. PMID: 10371697
-
Electrophysiologic and antiarrhythmic actions of sulphinpyrazone and its sulfide metabolite G25671.Pharmacology. 1987;34(2-3):121-30. doi: 10.1159/000138261. Pharmacology. 1987. PMID: 3108907
Cited by
-
Protection of rat atrial myocardium against electrical, mechanical and structural aspects of injury caused by exposure in vitro to conditions of simulated ischaemia.Br J Pharmacol. 1988 Aug;94(4):1207-17. doi: 10.1111/j.1476-5381.1988.tb11640.x. Br J Pharmacol. 1988. PMID: 3207981 Free PMC article.
-
Electrical changes produced by injury to the rat myocardium in vitro and the protective effects of certain antiarrhythmic drugs.Br J Pharmacol. 1987 Jan;90(1):131-8. doi: 10.1111/j.1476-5381.1987.tb16832.x. Br J Pharmacol. 1987. PMID: 3814915 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous